Screener
Stoke Therapeutics, Inc. STOK Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | $366,681 | $305,700 |
| Marketable securities - long-term | 67,481 | 106,260 |
| Restricted cash - long-term | 3,227 | 227 |
| Operating lease right-of-use assets | 2,493 | 3,101 |
| Property and equipment, net | 3,395 | 3,146 |
| Total assets | $443,277 | $418,434 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: |
Item 1. Financial Statements.
FAQ
- What is Stoke Therapeutics, Inc.'s operating lease ROU assets?
- Stoke Therapeutics, Inc. (STOK) reported operating lease ROU assets of $2.49M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Stoke Therapeutics, Inc.'s operating lease ROU assets decreased by 34.9% year-over-year, from $3.83M to $2.49M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s operating lease ROU assets has grown at a 22.7% compound annual growth rate (CAGR), from $1.12M to $3.1M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Stoke Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude